Related Experiment Video
Updated: Sep 28, 2026

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
Published on: February 10, 2013
Dopamine may preserve the myocardial oxygen balance better than dobutamine when administered with milrinone
Isao Takamatsu1, Fujio Karasawa, Tomohiro Okuda
1Department of Anesthesiology, National Defense Medical College, Tokorozawa, Saitama, Japan.
Purpose:
To compare the hemodynamic effects of dopamine with those of dobutamine when administered with milrinone in patients undergoing non-cardiac surgery.
Methods:
In 14 patients undergoing major surgery during anesthesia with isoflurane, milrinone (50 microgram*kg(-1) followed by 0.25 microgram*kg(-1)*min(-1)) was administered. Hemodynamic baseline values were assessed 50 min after continuous infusion of milrinone. Additional infusion of either dopamine or dobutamine, randomly selected, was started at the rate of 4 and later 8 microgram*kg(-1)*min(-1); each hemodynamic variable was measured 20 min after changing the infusion rate. One hour after ceasing the infusion of one catecholamine (dopamine or dobutamine), the other was infused at the rate of 4 and 8 microgram*kg(-1)*min(-1).
Results:
Milrinone increased heart rate (HR), but decreased mean arterial pressure (MAP) and systemic vascular resistance (SVR) (P < 0.05 for each). Dopamine administered with milrinone significantly increased MAP and cardiac output (CO), whereas dobutamine significantly increased HR and CO, but decreased SVR. By comparison between dopamine and dobutamine administered at the rate of 8 microgram*kg(-1)*min(-1), there was a significant difference in HR, MAP, and SVR (P < 0.01, 0.01, and 0.05, respectively).
Conclusion:
Dopamine and dobutamine administered with milrinone induce different hemodynamic changes: dopamine increases MAP without affecting HR, whereas dobutamine increases HR. Our data suggest that the myocardial oxygen balance might be better preserved with dopamine than with dobutamine when administered with milrinone.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: β-Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure V: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Drugs Affecting Neurotransmitter Synthesis